The closing price of Molina Healthcare Inc (NYSE: MOH) was $380.92 for the day, down -5.76% from the previous closing price of $404.20. In other words, the price has decreased by -$23.28 from its previous closing price. On the day, 687367 shares were traded.
Ratios:
Our analysis of MOH’s different ratios will help us gain a deeper understanding of the company. In the meantime, Its Debt-to-Equity ratio is 0.59 whereas as Long-Term Debt/Eq ratio is at 0.59.
On March 06, 2024, Barclays started tracking the stock assigning a Equal Weight rating and target price of $437.
Wells Fargo Upgraded its Underweight to Equal Weight on February 15, 2024, whereas the target price for the stock was revised from $367 to $420.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 20 ’24 when Schapiro Richard M sold 1,000 shares for $401.05 per share. The transaction valued at 401,050 led to the insider holds 11,207 shares of the business.
WOLF DALE B sold 1,500 shares of MOH for $597,570 on Feb 15 ’24. The Director now owns 14,867 shares after completing the transaction at $398.38 per share. On Feb 15 ’24, another insider, ORLANDO STEVEN J, who serves as the Director of the company, sold 750 shares for $399.12 each. As a result, the insider received 299,340 and left with 18,701 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MOH now has a Market Capitalization of 23.68B and an Enterprise Value of 16.96B. As of this moment, Molina’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.26, and their Forward P/E ratio for the next fiscal year is 14.15. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.21. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.65 while its Price-to-Book (P/B) ratio in mrq is 5.24. Its current Enterprise Value per Revenue stands at 0.50 whereas that against EBITDA is 9.72.
Stock Price History:
Over the past 52 weeks, MOH has reached a high of $423.92, while it has fallen to a 52-week low of $266.35. The 50-Day Moving Average of the stock is 389.92, while the 200-Day Moving Average is calculated to be 348.18.
Shares Statistics:
MOH traded an average of 383.27K shares per day over the past three months and 299.57k shares per day over the past ten days. A total of 58.00M shares are outstanding, with a floating share count of 57.92M. Insiders hold about 1.13% of the company’s shares, while institutions hold 100.05% stake in the company. Shares short for MOH as of Mar 15, 2024 were 1.43M with a Short Ratio of 3.73, compared to 1.66M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.44% and a Short% of Float of 2.78%.
Earnings Estimates
The firm’s stock currently is rated by 14 analysts. On average, analysts expect EPS of $5.62 for the current quarter, with a high estimate of $6.36 and a low estimate of $5.21, while EPS last year was $5.81. The consensus estimate for the next quarter is $5.66, with high estimates of $6.29 and low estimates of $5.25.
Analysts are recommending an EPS of between $24 and $23.5 for the fiscal current year, implying an average EPS of $23.68. EPS for the following year is $27.11, with 14 analysts recommending between $29.23 and $26.37.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 12 analysts. It ranges from a high estimate of $9.76B to a low estimate of $8.79B. As of the current estimate, Molina Healthcare Inc’s year-ago sales were $8.33B, an estimated increase of 13.30% from the year-ago figure. For the next quarter, 12 analysts are estimating revenue of $9.69B, an increase of 16.40% over than the figure of $13.30% in the same quarter last year. There is a high estimate of $9.8B for the next quarter, whereas the lowest estimate is $9.59B.
A total of 14 analysts have provided revenue estimates for MOH’s current fiscal year. The highest revenue estimate was $39.73B, while the lowest revenue estimate was $37.27B, resulting in an average revenue estimate of $39.33B. In the same quarter a year ago, actual revenue was $34.07B, up 15.40% from the average estimate. Based on 13 analysts’ estimates, the company’s revenue will be $42.55B in the next fiscal year. The high estimate is $44.31B and the low estimate is $41.27B. The average revenue growth estimate for next year is up 8.20% from the average revenue estimate for this year.
